Trials / Completed
CompletedNCT04309617
Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy
Provider Referral Patterns Following Nephrectomy in High-Risk Locoregional Renal Cell Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 618 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at estimating the proportion of patients diagnosed with locoregional renal cell carcinoma who are at high risk for recurrence following nephrectomy, describe referral patterns, and characterize treatment in this population. Outcomes including estimation of the incidence of recurrence and disease-free interval following nephrectomy will be reported overall and among the subgroup off patients receiving adjuvant systemic therapy with sunitinib following nephrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | nephrectomy | Surgery performed within the study period |
Timeline
- Start date
- 2019-07-31
- Primary completion
- 2020-04-28
- Completion
- 2020-04-28
- First posted
- 2020-03-16
- Last updated
- 2021-05-19
- Results posted
- 2021-05-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04309617. Inclusion in this directory is not an endorsement.